1.Assessment of iron bioavailability in ten kinds of Chinese wheat flours using an in vitro digestion/Caco-2 cell model.
Ji LEI ; Yong ZHANG ; Xiang Gui CHEN ; Ming Qiu ZHANG ; Lin BAI ; Cheng Yu HUANG ; Ortiz Monasterio IVAN
Biomedical and Environmental Sciences 2012;25(5):502-508
OBJECTIVETo compare iron bioavailability (Fe BV) from ten selected kinds of Chinese wheat flours in order to provide scientific basis for further human trials and enable plant breeding programs to screen biofortified wheat cultivars.
METHODSAn in vitro digestion/Caco-2 cell model was used to assess Fe BV of ten flour samples from six leading Chinese wheat cultivars and the stability of Fe BV in one cultivar was studied across three growing environments.
RESULTSSignificant differences were observed in both Fe BV and Fe bioavailability per gram of food (Fe BVPG) among cultivars (P<0.01) grown at the same location with the same flour extraction rate. Zhongyou 9507 and Jingdong 8 had Fe BV 37%-54% and Fe BVPG 103%-154% higher than the reference control. In the Anyang environment, Zhongyou 9507 had a higher wheat flour-Fe level and Fe BVPG. Differences in Fe BV were detected in cultivars with different flour extraction rates.
CONCLUSIONZhongyou 9507 and Jingdong 8 were identified as the most promising cultivars for further evaluation of efficacy by using human subjects. The growing environments had no effect on Fe BV, but did have a significant effect on Fe BVPG. Fe bioavailabilities in low-extraction (40%) flours were higher than those in high-extraction (78%) flours.
Biological Availability ; Caco-2 Cells ; China ; Ferritins ; chemistry ; Flour ; analysis ; Genetic Variation ; Humans ; Iron ; chemistry ; pharmacokinetics ; Phosphorus ; chemistry ; Phytic Acid ; chemistry ; Triticum ; chemistry ; genetics
2.Pregabalin as a Neuroprotector after Spinal Cord Injury in Rats: Biochemical Analysis and Effect on Glial Cells.
Kee Yong HA ; Eugene CARRAGEE ; Ivan CHENG ; Soon Eok KWON ; Young Hoon KIM
Journal of Korean Medical Science 2011;26(3):404-411
As one of trials on neuroprotection after spinal cord injury, we used pregabalin. After spinal cord injury (SCI) in rats using contusion model, we observed the effect of pregabalin compared to that of the control and the methylprednisolone treated rats. We observed locomotor improvement of paralyzed hindlimb and body weight changes for clinical evaluation and caspase-3, bcl-2, and p38 MAPK expressions using western blotting. On histopathological analysis, we also evaluated reactive proliferation of glial cells. We were able to observe pregabalin's effectiveness as a neuroprotector after SCI in terms of the clinical indicators and the laboratory findings. The caspase-3 and phosphorylated p38 MAPK expressions of the pregabalin group were lower than those of the control group (statistically significant with caspase-3). Bcl-2 showed no significant difference between the control group and the treated groups. On the histopathological analysis, pregabalin treatment demonstrated less proliferation of the microglia and astrocytes. With this animal study, we were able to demonstrate reproducible results of pregabalin's neuroprotection effect. Diminished production of caspase-3 and phosphorylated p38 MAPK and as well as decreased proliferation of astrocytes were seen with the administration of pregabalin. This influence on spinal cord injury might be a possible approach for achieving neuroprotection following central nervous system trauma including spinal cord injury.
Animals
;
Apoptosis/drug effects
;
Astrocytes/drug effects/pathology
;
Blotting, Western
;
Body Weight/drug effects
;
Caspase 3/genetics
;
Cell Proliferation
;
Fluorescent Antibody Technique
;
Gene Expression
;
Hindlimb/drug effects/pathology/physiopathology
;
Inflammation
;
Male
;
Methylprednisolone/therapeutic use
;
Microglia/drug effects/pathology
;
Motor Activity/drug effects
;
Neuroglia/*drug effects/pathology
;
Neuroprotective Agents/*therapeutic use
;
Paralysis/drug therapy
;
Proto-Oncogene Proteins c-bcl-2/genetics
;
Rats
;
Rats, Sprague-Dawley
;
Spinal Cord Injuries/*drug therapy/pathology
;
gamma-Aminobutyric Acid/*analogs & derivatives/therapeutic use
;
p38 Mitogen-Activated Protein Kinases/genetics
3.Novel application of Influenza A virus-inoculated chorioallantoic membrane to characterize a NP-specific monoclonal antibody for immunohistochemistry assaying
Yang Chang TU ; Kuang Yu CHEN ; Chung Kung CHEN ; Ming Chu CHENG ; Shu Hwae LEE ; Ivan Chen CHENG
Journal of Veterinary Science 2019;20(1):51-57
Monoclonal antibodies (MAbs) are widely applied in disease diagnoses. Herein, we report a MAb, WF-4, against Influenza A virus nucleoprotein (NP), its broad response with Influenza A virus, and its application in an immunohistochemistry (IHC) assay. WF-4 was screened by immunofluorescence assay (IFA). The results showed that its reactivity with baculovirus-expressed full-length recombinant NP (rNP) in Western blot (WB), indicating its IHC applicability. Fifteen Influenza A virus (reference subtypes H1 to H15) infected chicken embryonated chorioallantoic membranes (CAM), fixed by formalin, were all detectable in the WF-4-based IHC assay. Also, the reactivity of the IHC test with NP from experimentally inoculated H6N1 and from all recent outbreaks of H5 subtype avian Influenza A virus (AIV) field cases in Taiwan showed positive results. Our data indicate that CAM, a by-product of Influenza A virus preparation, is helpful for Influenza A virus-specific MAb characterization, and that the WF-4 MAb recognizes conserved and linear epitopes of Influenza A virus NP. Therefore, WF-4 is capable of detecting NP antigens via IHC and may be suitable for developing various tests for diagnosis of Influenza A virus and, especially, AIV infection.
Animals
;
Antibodies, Monoclonal
;
Blotting, Western
;
Chickens
;
Chorioallantoic Membrane
;
Diagnosis
;
Disease Outbreaks
;
Epitopes
;
Fluorescent Antibody Technique
;
Formaldehyde
;
Immunohistochemistry
;
Influenza A virus
;
Influenza in Birds
;
Influenza, Human
;
Nucleoproteins
;
Taiwan